Influence of the duration of psoriatic arthritis on the achievement of remission and minimal disease activity during therapy with genetically engineered biologic drugs. Data from the all-russian register of patients with psoriatic arthritis

Aim. To study the frequency and timing of the onset of remission and minimal disease activity after the administration of genetically engineered biologic drugs (GEBD) in patients with early and long-term psoriatic arthritis observed within the framework of the All-Russian register of patients with p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, M. V. Sedunova, I. N. Pristavskiy, I. N. Kushnir, I. F. Umnova, S. S. Kudishina, E. L. Nasonov
Formato:	Artigo
Idioma:	Russo
Publicado em:	IMA PRESS LLC 2021-01-01
coleção:	Научно-практическая ревматология
Assuntos:	early psoriatic arthritis genetically engineered biologic drugs remission minimal disease activity
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/2970
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!